Laura Trives-Folguera

6PUBLICATIONS
27CO-AUTHORS
Regenerative medicine (incl. stem cells)Cardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersOptical technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 24, 2025
Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysis.

Daniel Clemente, Leticia Leon, Juan Carlos Nieto-Gonzalez

|Jan 25, 2025
Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors.

Elisabet Castañeda-Estévez, Cristina Vergara-Dangond, Martina Steiner

|Aug 01, 2023
What to Expect When Systemic Treatment in Juvenile Idiopathic Arthritis Is Withdrawn?

Juan Carlos Nieto-González, Daniel Clemente Garulo, Alina Boteanu

|Apr 07, 2023
Oral or pulse glucocorticoid use at the onset of giant cell arteritis and its influence on the risk of relapse: a retrospective study.

Laura Trives-Folguera, Juan Molina-Collada, Katerine López

|Jun 06, 2022
The role of ultrasound and FDG-PET/CT to detect extracranial artery involvement in patients with suspected large vessel vasculitis.

Juan Molina-Collada, Isabel Castrejón, Javier Rivera

|Feb 03, 2022
New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword?

Ana M Anzola, Laura Trives, Julia Martínez-Barrio

Pageof 1

Frequent Collaborators

3 joint publications

Julia Martínez-Barrio

3 joint publications

José María Álvaro-Gracia

3 joint publications

Juan Molina-Collada

2 joint publications

Ana M Anzola-Alfaro